Clinical trial for Malaria Vaccine Study
The FMP013/FMP014 vaccines have been designed to prevent malaria caused by Plasmodium falciparum. This is the first time these vaccine will be tested in humans.
The FMP013/FMP014 vaccines have been designed to prevent malaria caused by Plasmodium falciparum. This is the first time these vaccine will be tested in humans.
“Phase 1, Randomized, Double-Blinded, Single-Dose Escalation Study Followed by a Multiple-Dose Escalation Study of SKL24741 in Healthy Subjects” Spaulding Clinical is currently looking for healthy
“A Phase 1, Single-Center, Randomized, Double-Blind, Placebo-Controlled, Single-Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of RZ402 in Healthy Subjects” Spaulding Clinical is
“A Single-Center, Randomized, Open-Label, Single-Dose, Fully Replicated, 2-Treatment, 2-Sequence, 4-Period Crossover Study to Evaluate the Relative Bioavailability of Armour® Thyroid Tablets Using Different Active Pharmaceutical
This study involves one screening visit,1 in-house stay of 8 Days / 7 Nights
The WRAIR Clinical Trials Center is seeking healthy adults ages 18-55 with no previously documented Covid-19 infection to participate in a Specimen Collection Study. Participants
Healthy male and females aged 18-45. BMI 18-30. Long term… One-23 night stay & 1 phone call. Stipend $7,845.00
The Clinical Trials Center (CTC) was established in early 1992 to support Army and Navy investigators in their mission to develop new vaccines, drugs, and
Healthy male and females aged 18-45. BMI 18-30. Long term… One-23 night stay & 1 phone call. Stipend $7,845.00
“A Phase 1, Pharmacokinetic Comparability Study of Intravenous and Subcutaneous Administration of Risankizumab in Healthy Subjects” Healthy male and female volunteers between the ages of